Michael B. Chancellor, MD, is the Director of Neurourology Program in the Department of Urology at the William Beaumont Hospital in Royal Oak, Michigan. Dr. Michael Chancellor, board certified by the American Board of Urology, received his medical degree from Medical College of Wisconsin in Milwaukee. He completed his internship in surgery and his residency in urology at the University of Michigan in Ann Arbor. He subsequently completed his fellowship in neurourology and female urology at Columbia University and College of Physicians and Surgeons in New York.

Dr. Chancellor is a world-renowned author and speaker, and has been invited to present more than 650 papers at national and international meetings. He has appeared on CNN, in the pages of the Wall Street Journal, and in numerous television and radio interviews. Dr. Chancellor has written over 550 peer-reviewed articles and book chapters in journals including The Journal of Urology, Urology, Gene Therapy, and Lancet. He has also written 11 books and serves on the editorial board of 12 scientific journals.

A prolific author and researcher, Dr. Chancellor has gained national and international recognition in the areas of stem cell and tissue engineering, drug discovery, and  was the first urologist to use Botox to treat lower urinary tract dysfunction. He is the founder of Cook MyoSite, Inc., that is now in multicenter North American trial using adult autologous muscle derived stem cells to treat stress urinary incontinence. Dr. Chancellor has received a number of prestigious awards, including the Paul Zimkin Award, from The Urodynamics Society, grand prizewinner of the International Jack Lapides Essay Contest and The Pfizer-American Urological Association Visiting Professorship Award. He was recognized as Innovator of the Year by the Pittsburgh Magazine and one of the "Best Doctors in America."

Dr. Chancellor has received funding from the National Institutes of Health for over a decade and he has trained many of today's experts in urology.